Palo Alto Investors LP Ptc Therapeutics, Inc. Transaction History
Palo Alto Investors LP
- $501 Million
- Q1 2025
A detailed history of Palo Alto Investors LP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 404,196 shares of PTCT stock, worth $20 Million. This represents 4.11% of its overall portfolio holdings.
Number of Shares
404,196
Previous 386,413
4.6%
Holding current value
$20 Million
Previous $17.4 Million
18.09%
% of portfolio
4.11%
Previous 2.79%
Shares
3 transactions
Others Institutions Holding PTCT
# of Institutions
284Shares Held
78.5MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$426 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$385 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$371 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$269 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$269 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.54B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...